Asher Bio
We build better immunotherapies
Asher Bio is a biotechnology company developing precisely targeted immunotherapies for cancer and other diseases. Our cis-targeting platform aims to enable selective activation of specific immune cell types, addressing the inherent limitations of otherwise pleiotropic immunotherapies that act on multiple cell types. Our approach has the potential to precisely direct different immune mediators against a range of target immune cell-types and create best-in-class immunotherapies in cancer, autoimmune and infectious diseases. Asher Bio is backed by Third Rock Ventures and is located in South San Francisco.
- Website
- asherbio.com
- City
- San Francisco
- Country
- United States
- YC batch
- Summer 2019
- Team
- 3 people
- Stage
- Growth stage
- AI-native
- No
More Health & bio in San Francisco
Innovaccer$1.3bn
Indian digital healthcare company.
Thatch$1bn
Health benefits. Valued at $1bn (September 2026).
Chan Zuckerberg BiohubLab
Nonprofit research network building virtual cell models.
AthelasHiring
Extensible, Integrated Technology that Simplifies Health Systems
ClipboardHiring
Every shift, Covered.
Benchling
Unlocking the power of biotech with modern software for modern science
Claim this profile
Free and instant: prove you run asherbio.com and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to Asher Bio across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with Asher Bio's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
